phase ii study of tosedostat in mds
Published 3 years ago • 24 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
1:45
a phase ii study of elritercept for lower-risk mds
-
1:41
an overview of the mds diagnosis pathway
-
1:30
stimulus-mds1: phase ii study of sabatolimab added to hmas in high-risk mds
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:19:32
autophagy lecture
-
46:01
yoshinori ohsumi: what is autophagy? a dynamic cellular recycling process
-
20:18
surgical phase 2
-
3:52
a phase ii study evaluating the safety and efficacy of olutasidenib in patients with r/r midh1 aml
-
2:47
molecular background studies to aid diagnosis and treatment of mds
-
0:48
an introduction to the maxilus study: the optimal dose of luspatercept in lr-mds
-
2:58
long-term follow-up: phase ii study of apr-246 aza in tp53-mutated mds & aml
-
2:52
long-term evaluation of luspatercept in esa-intolerant/refractory lr-mds: medalist follow-up study
-
1:04
the future of mds management
-
14:38
hematology in 10 min hemostasis and coagulation mp4 final
-
2:36
phase ii study of pre-, during-, and post-transplant ruxolitinib for patients with myelofibrosis
-
2:04
state-of-the-art treatment for hr-mds
-
5:43
pre- and post-allohsct treatment in mds
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
1:44
imerge update: continuous transfusion independence & disease modification with imetelstat in lr-mds
-
1:48
a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis